ライフサイエンスコーパス: to evaluate

1 To evaluate if the up-regulation of vascular endothelial grow

2 To evaluate the existence of an interaction between wine prot

3 To evaluate the performance of this scheme, we performed a cg

4 To evaluate the potential role of these residues in hydrophob

5 To evaluate the prevalence of pathogenic CNVs and identify po

6 To evaluate the relationship between hospital teaching intens

7 To evaluate the safety and intraocular pressure (IOP)-lowerin

8 To evaluate vascular cells, von Willebrand factor (vWF) and v

9 d international scale connectivity assessments with stage 2 to evaluate possible spread of local outbreaks nationally, re

10 The ability to evaluate and cross-compare multiple drugs and drug combina

11 This study aimed to evaluate clinical response and survival in patients receiv

12 We aimed to evaluate the efficacy of the parenteral (intravenous or in

13 We used multivariate analyses to evaluate clinicopathological and perioperative factors for

14 We used decision-curve analysis to evaluate the clinical usefulness of each score and the pri

15 We conducted a systematic review and meta-analysis to evaluate the evidence for their use in this setting.

16 oluble vitamin loading in re-assembled casein micelles, and to evaluate vitamin D stability of dry formulations during am

17 ence of other autoimmune diseases, to control relapses, and to evaluate psychophysical sequelae.

18 Our results provide a basis to evaluate regional emission inventories.

19 ospective, international 1:1 randomized trial was conducted to evaluate in a noninferiority design the relative safety an

20 A complete method validation procedure was conducted to evaluate the effectiveness of this quantitative screening

21 randomized, placebo-controlled trials specifically designed to evaluate statin therapy in patients with cancer.

22 This is a cross-sectional study designed to evaluate the histologic characteristics of graft injury in

23 This makes it extremely difficult to evaluate the relative added value of each new treatment.

24 del of MS, experimental autoimmune encephalomyelitis (EAE), to evaluate the hypothesis that the loss of plasminogen would

25 reinstatement of drug use, we formulated intranasal insulin to evaluate its efficacy during acute abstinence from smoking

26 The objective of the current study is to evaluate differences in outcome by applying five periodont

27 on these simulation tools, we have developed a first method to evaluate the parameters of this propagation model.

28 We applied restricted cubic spline models to evaluate the dose-response relationships.

29 However, further studies are needed to evaluate whether the control of metabolic parameters can l

30 alyses with aminoglycoside-treated patients are needed next to evaluate a possible interference of selenoprotein biosynth

31 Analysis of variance was performed to evaluate linear, quadratic and interaction effects between

32 Purpose To evaluate the diagnostic performance and examination succes

33 rformed whole-genome sequencing of nosocomial MDRPa strains to evaluate genotypic relationships between isolates.

34 Limited proof-of-concept monotherapy studies to evaluate safety and antiviral activity should be conducted

35 usion Serial multiparametric MR imaging mapping can be used to evaluate cartilage beyond mere static analysis and may pro

36 Logistic regression was used to evaluate the association between race/ethnicity and pallia

37 PET imaging was used to evaluate the whole-body distribution of (89)Zr-deferoxamin

38 nd-Altman plots and 95% limits of agreement (LoA) were used to evaluate agreement between device pairs.

39 Multivariable binomial regression models were used to evaluate the effects of oral health, general health, and s

40 e population with data from liver transplantation waitlists to evaluate changes in the burden of liver disease in the Uni

41 clinical trials of terlipressin with albumin are warranted to evaluate real-world effectiveness and safety in patients w

42 Our goal was to evaluate this test using PB against larger numbers of Ente

43 Our objective was to evaluate the biodistribution, kinetics, and radiation dosi

44 The aim of this study was to evaluate the fate of fumonisins B1 (FB1) and B2 (FB2) duri

45 The aim of this study was to evaluate the impact of patient-provider communication on m

46 The aim of this study was to evaluate the impact of the sample reconstitution solvent c

47 Therefore, the aim of the current study was to evaluate the prognostic value of MPI performed with a CZT

48 The aim of this study was to evaluate the role of miR-125a-5p in VSMCs phenotypic switc

49 The aim of this study was to evaluate the role of resistance to the antilipolytic effec

50 The primary objective of this trial was to evaluate safety of IVT or an estradiol vaginal ring in pat